Download
HTML Embed
HTML EMBED
Click to Copy

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace

The nest is full

Oct 11, 2019
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy

Would a $10 billion Purdue settlement reach towns affected by the opioid crisis?

by Kai Ryssdal and Caitlin Esch Aug 28, 2019
A proposed settlement would reportedly see the OxyContin maker declaring bankruptcy and paying big. Is that enough for people on the ground?
A homemade sign says "Think drugs gets you high give God a try," on a front lawn in Big Stone Gap, Virginia. The town in Wise County has been hit hard by the opioid epidemic.
Julia Rendleman/Marketplace
The Uncertain Hour

OxyContin maker Purdue Pharma to stop marketing opioids to doctors

by Marketplace Staff and Associated Press Feb 10, 2018
Purdue’s promotions exaggerated the drug’s safety and risks of addiction, leaning heavily on one sentence used by sales reps to market the drug to doctors.
The prescription medicine OxyContin is displayed Aug. 21, 2001 at a Walgreens drugstore.
Darren McCollester/Getty Images
The Uncertain Hour

How one sentence helped set off the opioid crisis

by Caitlin Esch Dec 13, 2017
Recently unsealed documents shed light on how the maker of OxyContin seems to have relied more on focus groups than on scientific studies to create an aggressive and misleading marketing campaign that helped fuel the national opioid epidemic.
A candlelight vigil recognizing the nation's opioid addiction crisis in Washington, D.C.
Alex Wong/Getty Images

OxyContin's waiting game: Generic drug makers salivate while the FDA wants safer pills

by Dan Gorenstein Apr 16, 2013
OxyContin is supposed to come off patent and generic drug makers are excited. But, the FDA may put a stop to it all to wait for safer pills.